IDO2 and diabetic retinopathy: In a case–control study that conducted targeted metabolomics assays for serum tryptophan and its metabolites, Munipally et al [36] identified elevated levels of indoleamine 2,3-dioxygenase and kynurenines among participants with diabetic retinopathy (n=46) vs control individuals (n=35).